Evidence map›Paper›PMID 35138047›Full record

ArticleBrain and behavior2022

The quality of life in patients with Parkinson's disease: Focus on gender difference.

Detao Meng, Zhaohui Jin, Lei Gao, Yixuan Wang, Ruidan Wang, Jinping Fang, Lin Qi, Yuan Su, Aixian Liu, Boyan Fang

Abstract read
In one paragraph

Article in Brain and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Detao MengParkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Zhaohui JinParkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Lei GaoParkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Yixuan WangParkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Ruidan WangParkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Jinping FangParkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Lin QiParkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Yuan SuParkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Aixian LiuParkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Boyan FangParkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-9935-433X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo improve understanding of gender differences on quality of life (QoL) in patients with Parkinson's disease (PWP) of a different race, the differences of clinical features and health-related quality of life (HRQoL) between male and female PWP were studied in a small cohort early to middle stage of Chinese PWP.

methodsA cross-sectional study was carried out. PWP were consecutively included from April 2020 to July 2021 in Beijing Rehabilitation Hospital. HRQoL, motor symptoms, and nonmotor symptoms in each patient were evaluated. The differences of demographic, motor symptoms assessments, nonmotor symptoms assessments, and QoL between two gender groups were tested using t-test statistics, Mann-Whitney-Wilcoxon test, or χ

resultsOne hundred and sixty-two Parkinson's disease (PD) patients were included. Demographic, clinical characteristics, and symptom scale assessments had no statistical differences except for levodopa equivalent daily dose, Hamilton Anxiety Rating Score, REM sleep behavior disorder sleep questionnaire, and Hyposmia Rating Scale score. After baseline imbalance corrections, a significantly higher score of PD Questionnaire-39 (PDQ-39) in female than in male patients(p<.05) was found. In the questionnaire, summary Index and bodily discomfort, stigma, and emotional well-being subscores were the main contribution differences.

conclusionsGender differences are associated with the QoL in the early to middle stage PWP in China. Female patients have poorer QoL than male patients, especially bodily discomfort, stigma, and emotional well-being.

Indexed as

Parkinson DiseaseQuality of LifeCross-Sectional StudiesFemaleHumansLevodopaMaleSex FactorsSurveys and QuestionnairesLevodopagenderhealth-related quality of lifeParkinson's diseasePDQ-39

Identifiers

PMID35138047
PMCPMC8933778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.